Mingjing Xu

3.1k total citations
38 papers, 2.3k citations indexed

About

Mingjing Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mingjing Xu has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Mingjing Xu's work include Cancer, Hypoxia, and Metabolism (10 papers), Epigenetics and DNA Methylation (6 papers) and Mitochondrial Function and Pathology (4 papers). Mingjing Xu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Epigenetics and DNA Methylation (6 papers) and Mitochondrial Function and Pathology (4 papers). Mingjing Xu collaborates with scholars based in Hong Kong, China and United States. Mingjing Xu's co-authors include Irene Oi‐Lin Ng, Chun‐Ming Wong, Carmen Chak‐Lui Wong, David Kung‐Chun Chiu, Robin Kit‐Ho Lai, Aki Pui‐Wah Tse, Jiangang Shen, Xingmiao Chen, Larry Lai Wei and Felice Ho‐Ching Tsang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mingjing Xu

34 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjing Xu Hong Kong 20 1.2k 742 507 470 260 38 2.3k
Matthew G. Annis Canada 27 2.0k 1.7× 827 1.1× 835 1.6× 484 1.0× 152 0.6× 44 3.0k
Sergio Marchini Italy 33 2.0k 1.8× 1.3k 1.7× 970 1.9× 273 0.6× 106 0.4× 105 3.6k
Kiyomu Fujii Japan 28 888 0.8× 421 0.6× 380 0.7× 221 0.5× 67 0.3× 75 1.9k
Fengfei Wang China 24 804 0.7× 431 0.6× 649 1.3× 164 0.3× 58 0.2× 39 1.8k
Meidan Ying China 34 2.2k 1.9× 813 1.1× 705 1.4× 493 1.0× 46 0.2× 95 3.3k
Andelko Hrzenjak Austria 32 1.4k 1.2× 604 0.8× 374 0.7× 224 0.5× 57 0.2× 63 2.5k

Countries citing papers authored by Mingjing Xu

Since Specialization
Citations

This map shows the geographic impact of Mingjing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjing Xu more than expected).

Fields of papers citing papers by Mingjing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjing Xu. The network helps show where Mingjing Xu may publish in the future.

Co-authorship network of co-authors of Mingjing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjing Xu. A scholar is included among the top collaborators of Mingjing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjing Xu. Mingjing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yanmei, et al.. (2025). Spliced exon9 ADRM1 promotes liver oncogenicity via selective degradation of tumor suppressor FBXW7. Journal of Hepatology. 83(1). 92–104. 1 indexed citations
2.
Xu, Mingjing, et al.. (2023). Ecosystem Services Supply–Demand Matching and Its Driving Factors: A Case Study of the Shanxi Section of the Yellow River Basin, China. Sustainability. 15(14). 11016–11016. 12 indexed citations
3.
Xu, Mingjing, Yue Liu, Alissa M. Wong, et al.. (2022). Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity. Cancer Letters. 548. 215898–215898. 10 indexed citations
4.
Li, Rui, Qi Li, Xiaoyi Li, et al.. (2022). Role of cerebellar cortex in associative learning and memory in guinea pigs. Open Life Sciences. 17(1). 1208–1216. 1 indexed citations
5.
Xu, Mingjing, Pınar Ülker, G. Esteban Fernández, et al.. (2021). Individual red blood cell nitric oxide production in sickle cell anemia: Nitric oxide production is increased and sickle shaped cells have unique morphologic change compared to discoid cells. Free Radical Biology and Medicine. 171. 143–155. 2 indexed citations
6.
Lee, Derek, Misty Shuo Zhang, Felice Ho‐Ching Tsang, et al.. (2021). Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species. Hepatology. 74(2). 776–796. 19 indexed citations
7.
Sun, Wei, Jing Zhou, Mingjing Xu, et al.. (2020). Mitochondrial DNA copy number in cervical exfoliated cells and risk of cervical cancer among HPV-positive women. BMC Women s Health. 20(1). 139–139. 12 indexed citations
8.
Chiu, David Kung‐Chun, Aki Pui‐Wah Tse, Cheuk‐Ting Law, et al.. (2019). Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway. Cell Death and Disease. 10(12). 934–934. 136 indexed citations
9.
Law, Cheuk‐Ting, Lai Wei, Felice Ho‐Ching Tsang, et al.. (2018). HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma. Hepatology. 69(5). 2013–2030. 59 indexed citations
10.
Tsang, Felice Ho‐Ching, David Kung‐Chun Chiu, Misty Shuo Zhang, et al.. (2018). Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis. 7(5). 44–44. 35 indexed citations
11.
Xu, Mingjing, Weiwei Li, Haihong Han, et al.. (2018). Retrospective case analysis of crayfish-transmitted Haff disease in China during 2016–2017. Food Control. 104. 181–186. 3 indexed citations
12.
Chiu, David Kung‐Chun, Aki Pui‐Wah Tse, Mingjing Xu, et al.. (2017). Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. Nature Communications. 8(1). 517–517. 342 indexed citations
13.
Lai, Robin Kit‐Ho, Mingjing Xu, David Kung‐Chun Chiu, et al.. (2016). NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma. Clinical Cancer Research. 22(12). 3105–3117. 69 indexed citations
14.
Ho, Daniel Wai‐Hung, Lo‐Kong Chan, Mingjing Xu, et al.. (2016). TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication. Gut. 66(8). 1496–1506. 87 indexed citations
15.
16.
Wong, Carmen Chak‐Lui, Sandy Leung–Kuen Au, Aki Pui‐Wah Tse, et al.. (2014). Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis. PLoS ONE. 9(12). e115036–e115036. 66 indexed citations
17.
Xu, Mingjing, Xingmiao Chen, Yong Gu, et al.. (2013). Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury. Journal of Ethnopharmacology. 150(1). 116–124. 76 indexed citations
18.
Chen, Xingmiao, Hansen Chen, Mingjing Xu, & Jiangang Shen. (2012). Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury. Acta Pharmacologica Sinica. 34(1). 67–77. 106 indexed citations
19.
Gu, Yong, Guo‐qing Zheng, Mingjing Xu, et al.. (2011). Caveolin‐1 regulates nitric oxide‐mediated matrix metalloproteinases activity and blood–brain barrier permeability in focal cerebral ischemia and reperfusion injury. Journal of Neurochemistry. 120(1). 147–156. 197 indexed citations
20.
Xu, Mingjing, Yue Li, Yong Gu, et al.. (2011). Free cholesterol accumulation impairs antioxidant activities and aggravates apoptotic cell death in menadione-induced oxidative injury. Archives of Biochemistry and Biophysics. 514(1-2). 57–67. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew G. Annis Breakdown of academic impact, for papers by Sergio Marchini Breakdown of academic impact, for papers by Kiyomu Fujii Breakdown of academic impact, for papers by Fengfei Wang Breakdown of academic impact, for papers by Meidan Ying Breakdown of academic impact, for papers by Andelko Hrzenjak
Rankless by CCL
2026